Leena Halim

550 total citations
7 papers, 360 citations indexed

About

Leena Halim is a scholar working on Oncology, Electrical and Electronic Engineering and Molecular Biology. According to data from OpenAlex, Leena Halim has authored 7 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Electrical and Electronic Engineering and 2 papers in Molecular Biology. Recurrent topics in Leena Halim's work include CAR-T cell therapy research (6 papers), Advancements in Semiconductor Devices and Circuit Design (3 papers) and Silicon Carbide Semiconductor Technologies (2 papers). Leena Halim is often cited by papers focused on CAR-T cell therapy research (6 papers), Advancements in Semiconductor Devices and Circuit Design (3 papers) and Silicon Carbide Semiconductor Technologies (2 papers). Leena Halim collaborates with scholars based in United Kingdom and United States. Leena Halim's co-authors include John Maher, David M. Davies, Lynsey M. Whilding, Ana C. Parente‐Pereira, Tomasz Zabinski, Benjamin Draper, Rosalind Hannen, Marco Romano, Giovanna Lombardi and Isabel Corrêa and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Leena Halim

5 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leena Halim United Kingdom 5 246 200 81 77 74 7 360
Won‐Ju Kim South Korea 10 180 0.7× 203 1.0× 63 0.8× 152 2.0× 53 0.7× 23 414
Roseanna M. Petrovic United Kingdom 5 238 1.0× 104 0.5× 86 1.1× 76 1.0× 65 0.9× 8 282
Anthony Leonardi United States 6 377 1.5× 292 1.5× 72 0.9× 139 1.8× 108 1.5× 10 518
Deanna Langfitt United States 8 246 1.0× 117 0.6× 75 0.9× 117 1.5× 71 1.0× 15 315
Takeya Masubuchi United States 6 186 0.8× 180 0.9× 50 0.6× 99 1.3× 30 0.4× 8 315
Caiying Jiang China 5 236 1.0× 130 0.7× 55 0.7× 61 0.8× 58 0.8× 7 277
Xiaoqian Liang China 6 243 1.0× 98 0.5× 54 0.7× 117 1.5× 68 0.9× 8 334
Paraskevi Dimou United Kingdom 6 205 0.8× 108 0.5× 53 0.7× 87 1.1× 32 0.4× 8 303
Caitlin Stashwick United States 10 295 1.2× 153 0.8× 63 0.8× 72 0.9× 76 1.0× 12 368
Dennis Christoph Harrer Germany 10 329 1.3× 175 0.9× 95 1.2× 139 1.8× 97 1.3× 35 403

Countries citing papers authored by Leena Halim

Since Specialization
Citations

This map shows the geographic impact of Leena Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leena Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leena Halim more than expected).

Fields of papers citing papers by Leena Halim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leena Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leena Halim. The network helps show where Leena Halim may publish in the future.

Co-authorship network of co-authors of Leena Halim

This figure shows the co-authorship network connecting the top 25 collaborators of Leena Halim. A scholar is included among the top collaborators of Leena Halim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leena Halim. Leena Halim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lopez, Michael, Ivan S. Kotchetkov, Leena Halim, et al.. (2025). pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication. Cell. 189(2). 401–417.e21.
2.
Halim, Leena, Kushal Kumar Das, Daniel Larcombe-Young, et al.. (2022). Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation. Frontiers in Immunology. 13. 836549–836549. 19 indexed citations
3.
Halim, Leena, Farideh Miraki‐Moud, David Taussig, et al.. (2021). Priming Death Receptor Mediated Apoptosis with Arginine Starvation Sensitises Arginine Auxotrophic B-ALL to CAR-T. Blood. 138(Supplement 1). 2787–2787.
4.
Halim, Leena & John Maher. (2020). CAR T-cell immunotherapy of B-cell malignancy: the story so far. SHILAP Revista de lepidopterología. 8. 2672389564–2672389564. 44 indexed citations
5.
Whilding, Lynsey M., Leena Halim, Benjamin Draper, et al.. (2019). CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies. Cancers. 11(5). 674–674. 166 indexed citations
6.
Halim, Leena, et al.. (2018). Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety. Best Practice & Research Clinical Haematology. 31(2). 117–125. 4 indexed citations
7.
Halim, Leena, Marco Romano, Reuben McGregor, et al.. (2017). An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment. Cell Reports. 20(3). 757–770. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026